DNA Repair in Prostate Cancer: Biology and Clinical Implications-Reference-Cited by-同舟云学术

DNA Repair in Prostate Cancer: Biology and Clinical Implications

Published:2017-03 Issue:3 Volume:71 Page:417-425
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Mateo Joaquin,Boysen Gunther,Barbieri Christopher E.,Bryant Helen E.,Castro Elena,Nelson Pete S.,Olmos David,Pritchard Colin C.,Rubin Mark A.,de Bono Johann S.

Publisher

Elsevier BV

Subject

Urology

Reference73 articles.

1. Sequencing of agents in castration-resistant prostate cancer;Lorente;Lancet Oncol,2015

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

3. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;N Engl J Med,2012

4. Genomic correlates to the newly proposed grading prognostic groups for prostate cancer;Rubin;Eur Urol,2015

5. Punctuated evolution of prostate cancer genomes;Baca;Cell,2013

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer;World Journal of Urology;2024-08-22

2. GSFM: A genome-scale functional module transformation to represent drug efficacy for in silico drug discovery;Acta Pharmaceutica Sinica B;2024-08

3. Unveiling Bladder Cancer Prognostic Insights by Integrating Patient-Matched Sample and CpG Methylation Analysis;Medicina;2024-07-19

4. The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancer;Cancer Treatment Reviews;2024-07

5. Identification of a prognostic DNA repair gene signature in esophageal cancer;Journal of Gastrointestinal Oncology;2024-06